V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190006694 | 190004250 | 1.82 | 24.9 | null | 2019-06-03 | 2019-06-05 | EW EuroEwing 2012 Arm B CE | 02 | N | CISPLATIN + GEMCITABINE | 101801435 |
| 190006699 | 190004251 | 1.64 | 88.3 | 03 | 2020-09-10 | 2020-09-19 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100486848 |
| 190006704 | 190004252 | 1.79 | 70.4 | Curative (C) | 2018-11-20 | 2018-11-20 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101572419 |
| 190006705 | 190004253 | null | 53.7 | null | 2016-08-23 | 2016-09-06 | EW EuroEwing 2012 Arm B VDC | N | Y | BEVACIZUMAB | 100636376 |
| 190006711 | 190004254 | 1.61 | 88 | null | 2019-07-09 | 2019-07-10 | DHAP | 02 | N | GEMCITABINE | 101790833 |
| 190006712 | 190004255 | 1.62 | 55.25 | null | 2018-11-06 | 2019-05-16 | OST Mifamurtide | 02 | N | AVELUMAB | 100026338 |
| 190006714 | 190004256 | 1.66 | 43 | Palliative (P) | 2016-07-09 | 2016-07-18 | Bortezomib + CYCLOPHOSPHAMIDE + Dexamethasone | 01 | N | RITUXIMAB | 100883060 |
| 190006715 | 190004257 | null | null | null | 2016-08-09 | 2016-09-02 | IMATINIB | 02 | N | GEMCITABINE | 100865928 |
| 190006716 | 190004258 | 1.57 | 52.8 | null | 2018-10-26 | 2018-10-26 | ETOPOSIDE | 01 | N | CISPLATIN + RT | 100702160 |
| 190006720 | 190004259 | 1.59 | 105.2 | Disease modification (D) | 2016-10-19 | 2017-04-02 | Capecitabine + Oxaliplatin 21day | 02 | N | CARBOPLATIN + ETOPOSIDE | 100516810 |
| 190006721 | 190004260 | null | 86 | Curative (C) | 2019-09-19 | 2019-10-05 | Capecitabine (14 days)+Carboplatin | 02 | null | NAB-PACLITAXEL | 101788215 |
| 190006723 | 190004261 | 1.66 | 62.1 | Palliative (P) | 2017-06-25 | 2017-11-03 | Cisplatin | 01 | N | CISPLATIN | 100193860 |
| 190006724 | 190004262 | 1.66 | 65.2 | Palliative (P) | 2018-04-20 | 2018-04-21 | NIVOLUMAB | null | Y | CISPLATIN + PEMETREXED | 100999814 |
| 190006727 | 190004263 | 1.6 | 60.3 | null | 2019-04-06 | 2019-04-26 | VAC | 02 | N | BEVACIZUMAB | 101716540 |
| 190006728 | 190004264 | 1.62 | 58 | Curative (C) | 2018-09-05 | 2018-12-04 | PACLITAXEL | 02 | N | FLUOROURACIL + IRINOTECAN | 101353381 |
| 190006730 | 190004265 | 1.68 | null | null | 2017-07-17 | 2017-08-09 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | TEMOZOLOMIDE | 101028538 |
| 190006733 | 190004266 | 1.72 | 71.3 | Curative (C) | 2018-07-23 | 2018-07-24 | VIDE | 01 | N | CISPLATIN + LIPOSOMAL DOXORUBICIN | 101683571 |
| 190006743 | 190004267 | 1.58 | null | Palliative (P) | 2016-02-28 | 2016-03-10 | Cyclophosphamide oral | 02 | N | CISPLATIN + GEMCITABINE | 101446983 |
| 190006744 | 190004268 | 1.63 | 39 | Adjuvant (A) | 2018-01-29 | 2018-09-18 | EW EuroEwing 2012 Arm B VDC | 02 | N | CAPECITABINE + CARBOPLATIN | 100727259 |
| 190006748 | 190004269 | 1.58 | 56.2 | Curative (C) | 2016-06-20 | 2016-07-10 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | DOCETAXEL + NINTEDANIB | 100719589 |
| 190006751 | 190004270 | 1.75 | 105.2 | Palliative (P) | 2019-06-23 | 2019-06-27 | EW EuroEwing 2012 Arm B IE | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101580044 |
| 190006754 | 190004271 | 1.55 | 108 | Curative (C) | 2021-06-22 | 2022-02-11 | Oxaliplatin + Modified de Gramont | N | N | CARBOPLATIN + ETOPOSIDE | 101614028 |
| 190006755 | 190004272 | 1.81 | 24.4 | Neo-adjuvant (N) | null | 2019-10-17 | Cisplatin + Doxorubicin | 02 | N | CAPECITABINE | 100618335 |
| 190006758 | 190004273 | 1.71 | 90.8 | Palliative (P) | null | 2016-09-18 | Carboplatin + Etoposide iv&po | null | null | FLUOROURACIL + IRINOTECAN | 100033864 |
| 190006759 | 190004274 | 1.73 | 70.5 | null | 2021-06-12 | 2021-11-08 | Bendamustine +/- Prednisolone | 01 | Y | CARBOPLATIN + GEMCITABINE | 101316247 |
| 190006762 | 190004275 | 1.54 | 86.15 | null | 2017-05-19 | 2017-05-26 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | BEVACIZUMAB | 101504152 |
| 190006764 | 190004276 | 1.72 | 48.7 | null | 2016-11-16 | 2017-06-05 | EW Rel rEECur Topotecan/Cyclophosphamide | 02 | N | BEP | 101164994 |
| 190006768 | 190004277 | null | 151 | Palliative (P) | 2016-02-09 | 2016-03-05 | EW Rel rEECur Irinotecan/Temozolomide | 02 | N | TRIAL UNSPECIFIED | 101011222 |
| 190006771 | 190004278 | 1.66 | 63.4 | null | 2020-03-23 | 2020-03-23 | BEAM | 02 | N | BEVACIZUMAB | 100657374 |
| 190006779 | 190004279 | null | 52.2 | null | 2016-09-05 | 2016-12-10 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | CISPLATIN | 100504252 |
| 190006783 | 190004280 | 1.6 | 68.3 | Neo-adjuvant (N) | 2016-12-13 | 2016-12-27 | Liposomal Doxorubicin 40mg/m2 | N | N | LIPOSOMAL DOXORUBICIN | 101329351 |
| 190006789 | 190004281 | 1.52 | 61.3 | Curative (C) | 2020-09-09 | 2021-08-20 | Gemcitabine weekly | 02 | N | PEMBROLIZUMAB | 100137018 |
| 190006791 | 190004282 | 0 | 31 | Curative (C) | 2016-04-03 | 2016-04-17 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 101559901 |
| 190006795 | 190004283 | 1.8 | 62.6 | Curative (C) | 2017-07-07 | 2017-07-13 | Carboplatin + Vinorelbine IV | 02 | N | PACLITAXEL | 100140841 |
| 190006798 | 190004284 | 1.74 | null | Palliative (P) | 2019-12-19 | 2019-12-25 | OST Mifamurtide | 02 | N | CISPLATIN + GEMCITABINE | 101007265 |
| 190006799 | 190004285 | null | 83.9 | Adjuvant (A) | null | 2018-12-28 | Docetaxel + nintedanib | 02 | null | CAPECITABINE + IRINOTECAN | 100664205 |
| 190006800 | 190004286 | 1.62 | 97.9 | Palliative (P) | 2017-09-07 | 2017-09-13 | Cisplatin 7 day | 02 | N | CISPLATIN | 101094021 |
| 190006801 | 190004287 | 0 | 30.6 | null | null | 2021-02-14 | Cisplatin + Radiotherapy | N | N | TRIAL UNSPECIFIED | 101187521 |
| 190006808 | 190004288 | 1.79 | 106.7 | Palliative (P) | 2018-05-09 | 2018-07-09 | Trial Unspecified | 02 | null | CARBOPLATIN + GEMCITABINE | 100604640 |
| 190006812 | 190004289 | 1.79 | 52 | Adjuvant (A) | null | 2021-03-20 | LANREOTIDE | 02 | null | CAPECITABINE | 101008390 |
| 190006815 | 190004290 | 1.87 | 64.8 | Curative (C) | 2017-12-30 | 2018-02-26 | CAPECITABINE + CARBOPLATIN | 02 | N | EOX | 100274158 |
| 190006819 | 190004291 | 1.72 | 58.2 | Curative (C) | 2019-12-14 | 2019-12-14 | Enzalutamide | null | null | NIVOLUMAB | 101442589 |
| 190006820 | 190004292 | 1.77 | 59.4 | Palliative (P) | 2016-09-02 | 2016-09-23 | EW EuroEwing 2012 Arm A VAI | 02 | null | TRIAL UNSPECIFIED | 101322674 |
| 190006823 | 190004293 | 0 | 12.8 | Adjuvant (A) | 2018-12-28 | 2018-12-28 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | null | CAPECITABINE + CISPLATIN | 101504882 |
| 190006827 | 190004294 | 1.73 | 48.3 | Adjuvant (A) | 2017-12-18 | 2018-01-15 | CARBOPLATIN | N | N | CARBOPLATIN | 100586716 |
| 190006828 | 190004295 | 1.76 | 46.5 | Palliative (P) | 2018-01-28 | 2018-02-21 | Cisplatin 7 day | 01 | N | CISPLATIN | 100840378 |
| 190006829 | 190004296 | 1.81 | 77.45 | Curative (C) | 2016-10-01 | 2016-10-06 | CARBOPLATIN + FLUOROURACIL | N | Y | BLEOMYCIN | 100921122 |
| 190006837 | 190004297 | 1.74 | 52.3 | Curative (C) | 2016-11-23 | 2016-11-29 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100531373 |
| 190006838 | 190004298 | 0 | 43.4 | Palliative (P) | 2017-11-20 | 2017-11-27 | Cyclophosphamide + Vincristine | 01 | null | AVELUMAB | 100864729 |
| 190006844 | 190004299 | 1.8 | 87.2 | Palliative (P) | 2018-06-16 | 2018-06-25 | CARBOPLATIN + ETOPOSIDE | N | null | TRIAL UNSPECIFIED | 100445431 |